Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: A systematic analysis of current evidence.

Autor: Adeloye D; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK., Owolabi EO; Centre for Global Surgery, Department of Global Health, Stellenbosch University, Stellenbosch, South Africa., Ojji DB; Department of Medicine, Faculty of Clinical Sciences, University of Abuja, Gwagwalada, Abuja, Nigeria., Auta A; School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, UK., Dewan MT; WHO Country Office for Nigeria, Abuja, Nigeria., Olanrewaju TO; Department of Medicine, College of Health Sciences, University of Ilorin, Ilorin, Nigeria., Ogah OS; College of Medicine, University of Ibadan, Ibadan, Nigeria., Omoyele C; Federal Ministry of Health, Abuja, Nigeria., Ezeigwe N; Federal Ministry of Health, Abuja, Nigeria., Mpazanje RG; WHO Country Office for Nigeria, Abuja, Nigeria., Gadanya MA; Department of Community Medicine, Aminu Kano Teaching Hospital, Bayero University, Kano, Nigeria., Agogo E; Resolve to Save Lives, Abuja, Nigeria., Alemu W; International Health Consultancy, LLC, Atlanta, GA, USA., Adebiyi AO; College of Medicine, University of Ibadan, Ibadan, Nigeria., Harhay MO; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Jazyk: angličtina
Zdroj: Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2021 May; Vol. 23 (5), pp. 963-977. Date of Electronic Publication: 2021 Feb 18.
DOI: 10.1111/jch.14220
Abstrakt: Improved understanding of the current burden of hypertension, including awareness, treatment, and control, is needed to guide relevant preventative measures in Nigeria. A systematic search of studies on the epidemiology of hypertension in Nigeria, published on or after January 1990, was conducted. The authors employed random-effects meta-analysis on extracted crude hypertension prevalence, and awareness, treatment, and control rates. Using a meta-regression model, overall hypertension cases in Nigeria in 1995 and 2020 were estimated. Fifty-three studies (n = 78 949) met our selection criteria. Estimated crude prevalence of pre-hypertension (120-139/80-89 mmHg) in Nigeria was 30.9% (95% confidence interval [CI]: 22.0%-39.7%), and the crude prevalence of hypertension (≥140/90 mmHg) was 30.6% (95% CI: 27.3%-34.0%). When adjusted for age, study period, and sample, absolute cases of hypertension increased by 540% among individuals aged ≥20 years from approximately 4.3 million individuals in 1995 (age-adjusted prevalence 8.6%, 95% CI: 6.5-10.7) to 27.5 million individuals with hypertension in 2020 (age-adjusted prevalence 32.5%, 95% CI: 29.8-35.3). The age-adjusted prevalence was only significantly higher among men in 1995, with the gap between both sexes considerably narrowed in 2020. Only 29.0% of cases (95% CI: 19.7-38.3) were aware of their hypertension, 12.0% (95% CI: 2.7-21.2) were on treatment, and 2.8% (95% CI: 0.1-5.7) had at-goal blood pressure in 2020. Our study suggests that hypertension prevalence has substantially increased in Nigeria over the last two decades. Although more persons are aware of their hypertension status, clinical treatment and control rates, however, remain low. These estimates are relevant for clinical care, population, and policy response in Nigeria and across Africa.
(© 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: